Corticosteroid + long-acting beta-2 agonist (LABA). Allow approx. 12hrs between doses. Asthma: ā„12yrs: initially 1 inh of 100/50 or 250/50 or 500/50 twice daily, based on disease severity and previous ...
Vectura's partner Hikma has launched its generic version of GlaxoSmithKlineās Advair Diskus (fluticasone propionate and salmeterol inhalation powder), in dosage strengths of 100mcg/50mcg and ...
GlaxoSmithKline's GSK treatment to reduce exacerbations in chronic obstructive pulmonary disease patients was approved by the U.S. Food and Drug Administration. The Research Triangle park, N.C., ...
Advair Diskus 250/50 is also indicated to reduce exacerbations in patients with a history of exacerbations. Advair Diskus 250/50 is the only approved strength for COPD because an efficacy advantage of ...
Hikma has resumed the launch of generic Advair Diskus following the Food and Drug Administrationās approval of an amendment Hikma submitted to its ANDA in January 2021. The amendment reflected ...
ROCKVILLE, Maryland (Reuters) - GlaxoSmithKline Plc's widely prescribed drug Advair is safe enough for treating asthma but two lesser-used medicines are too risky, a U.S. advisory panel ruled on ...
PHILADELPHIA, June 1, 2021 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced the U.S. Food and Drug Administration (FDA) has accepted the Abbreviated New Drug Application (ANDA) for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results